Humanization of a mouse monoclonal antibody directed against a cell surface-exposed epitope of membrane-associated heat shock protein 70 (Hsp70)

Molecular Biotechnology

Volumn 46, Issue 3, 2010, Pages 265-278

  Zettlitz, Kirstin A ^a   Seitter, Julia ^a   Müller, Dafne ^a   Kontermann, Roland E ^a  

^a UNIVERSITY OF STUTTGART   (Germany)

Author keywords

Cancer; CDR grafting; Chimeric antibody; Heat shock protein; Humanization

Indexed keywords

CANCER; CDR GRAFTING; CHIMERIC ANTIBODY; HEAT SHOCK PROTEIN; HUMANIZATION;

ALLERGIES; AMINO ACIDS; CELL MEMBRANES; CLONING; GRAFTING (CHEMICAL); MERGERS AND ACQUISITIONS; MONOCLONAL ANTIBODIES; SURFACE PLASMON RESONANCE;

PROTEINS;

AMINO ACID; CHIMERIC ANTIBODY; EPITOPE; HEAT SHOCK PROTEIN 70; HUMEX ANTIBODY; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CLONING; CONTROLLED STUDY; EPITOPE MAPPING; HUMAN; THERMOSTABILITY;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; BASE SEQUENCE; CELL LINE; CHO CELLS; CHROMATOGRAPHY, GEL; CRICETINAE; CRICETULUS; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; GLYCOSYLATION; HSP70 HEAT-SHOCK PROTEINS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 77958103554     PISSN: 10736085     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12033-010-9298-x     Document Type: Article

References (51)

1. S Linquist EA Craig 1988 The heat-shock proteins Annual Review of Genetics 22 631 677 10.1146/annurev.ge.22.120188.003215
2. SK Calderwood JR Theriault J Gong 2005 Message in a bottle: Role of the 70-kDa heat shock protein family in anti-tumor immunity European Journal of Immunology 35 2518 2527 1:CAS:528:DC%2BD2MXhtVOqsL%2FP 10.1002/eji.200535002 (Pubitemid 41404034)
3. MP Mayer B Bukau 2005 Hsp70 chaperones: Cellular functions and molecular mechanisms Cellular and Molecular Life Sciences 62 670 684 1:CAS:528: DC%2BD2MXktlymt78%3D 10.1007/s00018-004-4464-6
4. M Sherman G Multhoff 2007 Heat shock proteins in cancer Annals of the New York Academy of Sciences 1113 192 201 1:CAS:528:DC%2BD2sXhsVanurfE 10.1196/annals.1391.030 (Pubitemid 350015025)
5. VL Vega M Rodríguez-Silva T Frey M Gehrmann JC Diaz C Steinem G Multhoff N Arsipe A De Maio 2008 Hsp70 translocates into the plasma membrane after stress and is released into the extracellular environment in a membrane-associated form that activates macrophages Journal of Immunology 180 4299 4307 1:CAS:528:DC%2BD1cXisl2jtLc%3D
6. G Multhoff C Botzler M Wiesnet E Müller T Meier W Wilmanns RD Issels 1995 A stress-inducible 72-kDa heat-shock protein (HSP72) is expressed on the surface of human tumor cells, but not on normal cells International Journal of Cancer 61 272 279 1:CAS:528:DyaK2MXlsVCmtLY%3D 10.1002/ijc.2910610222
7. M Hantschel K Pfister A Jordan R Scholz R Andreesen G Schmitz H Schmetzer W Hiddemann G Multhoff 2000 Hsp70 plasma membrane expression on primary tumor biopsy material and bone marrow of leukemic patients Cell Stress and Chaperones 5 438 442 1:CAS:528:DC%2BD3MXkslyguw%3D%3D 10.1379/1466-1268(2000)005<0438: HPMEOP>2.0.CO;2 (Pubitemid 32057495)
8. B Farkas M Hantschel M Magyarlai B Becker K Scherer M Landthaler K Pfister M Gehrmann C Gross A Mackensen G Multhoff 2003 Heat shock protein 70 membrane expression and melanoma-associated marker phenotype in primary and metastatic melanoma Melanoma Research 13 147 152 1:CAS:528:DC%2BD3sXislyqsrs%3D 10.1097/00008390-200304000-00006 (Pubitemid 36583976)
9. T Kleinjung O Arndt HJ Feldmann U Bockmühl M Gehrmann T Zilch K Pfister J Schönberger J Marienhagen C Eilles L Rossbacher G Multhoff 2003 Heat shock protein 70 (Hsp70) membrane expression on head-and-neck cancer biopsy-a target for natural killer (NK) cells International Journal of Radiation Oncology, Biology, Physics 57 820 826 1:CAS:528:DC%2BD3sXns12rt7g%3D
10. M Gehrmann H Schmetzer G Eissner T Haferlach W Hiddemann G Multhoff 2003 Membrane-bound heat shock protein 70 (Hsp70) in acute myeloid leukemia: A tumor specific recognition structure for the cytolytic activity of autologous NK cells Haematologica 88 474 476
11. K Steiner M Graf K Hecht S Reif L Rossbacher K Pfister HJ Kolb HM Schmetzer G Multhoff 2006 High Hsp70-membrane expression on leukemic cells from patients with acute myeloid leukemia is associated with worse prognosis Leukemia 20 2076 2079 1:CAS:528:DC%2BD28XhtFWnsL3K 10.1038/sj.leu.2404391 (Pubitemid 44614913)
12. G Multhoff 2007 Heat shock protein 70 (Hsp70): Membrane location, export and immunological relevance Methods 43 229 237 1:CAS:528:DC%2BD2sXhtFers7%2FO 10.1016/j.ymeth.2007.06.006 (Pubitemid 47499077)
13. G Multhoff C Botzler L Jennen J Schmidt J Ellwart R Issels 1997 Heat shock protein 72 on tumor cells: A recognition structure for natural killer cells Journal of Immunology 158 4341 4350 1:CAS:528:DyaK2sXivVCksb0%3D
14. G Multhoff K Pfister C Botzler A Jordan R Scholz H Schmetzer R Burgstahler W Hiddemann 2000 Adoptive transfer of human natural killer cells in mice with severe combined immunodeficiency inhibits growth of Hsp70-expressing tumors International Journal of Cancer 88 791 797 1:CAS:528:DC%2BD3cXot1SqtLk%3D 10.1002/1097-0215(20001201)88:5<791::AID-IJC17>3.0.CO;2-I
15. G Multhoff K Pfister M Gehrmann M Hantschel C Gross M Hafner W Hiddemann 2001 A 14-mer Hsp70 peptide stimulates natural killer (NK) cell activity Cell Stress and Chaperones 6 337 344 1:CAS:528:DC%2BD38XivVOiuw%3D%3D 10.1379/1466-1268(2001)006<0337:AMHPSN>2.0.CO;2 (Pubitemid 33123486)
16. SW Krause R Gastpar R Andreesen C Gross H Ullrich G Thonigs K Pfister G Multhoff 2004 Treatment of colon and lung cancer patients with ex vivo heat shock protein 70-peptide-activated, autologous natural killer cells: A clinical phase I trial Clinical Cancer Research 10 3699 3707 1:CAS:528: DC%2BD2cXksVKnsbc%3D 10.1158/1078-0432.CCR-03-0683 (Pubitemid 38697603)
17. G Multhoff 2009 Activation of natural killer cells by heat shock protein 70 International Journal of Hyperthermia 25 169 175 1:CAS:528: DC%2BD1MXlvV2ksLo%3D 10.1080/02656730902902001
18. C Botzler G Li RD Issels G Multhoff 1998 Definition of extracellular localized epitopes of Hsp70 involved in an NK immune response Cell Stress and Chaperones 3 6 11 1:CAS:528:DyaK1cXislCjsL4%3D 10.1379/1466-1268(1998) 003<0006:DOELEO>2.3.CO;2 (Pubitemid 28159674)
19. C Moser C Schmidbauer U Gürtler C Gross M Gehrmann G Thonigs K Pfister G Multhoff 2002 Inhibition of tumor growth in mice with severe combined immunodeficiency is mediated by heat shock protein 70 (Hsp70)-peptide activated, CD94 positive natural killer cells Cell Stress and Chaperones 7 365 373 1:CAS:528:DC%2BD3sXksVyksQ%3D%3D 10.1379/1466-1268(2002)007<0365:IOTGIM>2. 0.CO;2 (Pubitemid 36008749)
20. C Gross W Koelch A DeMaio N Arispe G Multhoff 2003 Cell surface-bound heat shock protein 70 (Hsp70) mediates perforin-independent apoptosis by specific binding and uptake of granzyme B Journal of Biological Chemistry 278 41173 41181 1:CAS:528:DC%2BD3sXotFWgtbo%3D 10.1074/jbc.M302644200 (Pubitemid 37280943)
21. M Gehrmann M Brunner K Pfister A Reichle E Kremmer G Multhoff 2004 Differential up-regulation of cytosolic and membrane-bound heat shock protein 70 in tumor cells by anti-inflammatory drugs Clinical Cancer Research 10 3354 3364 1:CAS:528:DC%2BD2cXkt1GhsL8%3D 10.1158/1078-0432.CCR-03-0382 (Pubitemid 38685440)
22. R Gastpar C Gross L Rossbacher J Ellwart J Riegger G Multhoff 2004 The cell surface-localized heat shock protein 70 epitope TKD induces migration and cytolytic activity selectively in human NK cells Journal of Immunology 172 972 980 1:CAS:528:DC%2BD2cXnvVGn
23. R Gastpar M Gehrmann MA Bausero A Asea C Gross JA Schroeder G Multhoff 2005 Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells Cancer Research 65 5238 5247 1:CAS:528:DC%2BD2MXltFemu7w%3D 10.1158/0008-5472.CAN-04-3804 (Pubitemid 40827334)
24. K Pfister J Radons R Busch JG Tidball M Pfeifer L Freitag H-J Feldmann V Milani R Issels G Multhoff 2007 Patient survival by Hsp70 membrane phenotype Cancer 110 926 935 10.1002/cncr.22864 (Pubitemid 47257673)
25. X Liu LM Pop ES Vitella 2008 Engineering therapeutic monoclonal antibodies Immunological Reviews 222 9 27 1:CAS:528:DC%2BD1cXlsFejtr8%3D 10.1111/j.1600-065X.2008.00601.x (Pubitemid 351430363)
26. PJ Carter 2006 Potent antibody therapeutics by design Nature Reviews Immunology 6 343 357 1:CAS:528:DC%2BD28XjslOhu7o%3D 10.1038/nri1837
27. SJ Kim Y Park HJ Hong 2005 Antibody engineering for the development of therapeutic antibodies Molecules and Cells 20 17 29 1:CAS:528:DC%2BD2MXhtVGhtbnL
28. WY Hwang J Foote 2005 Immunogenicity of engineered antibodies Methods 36 3 10 1:CAS:528:DC%2BD2MXjsVegs7o%3D 10.1016/j.ymeth.2005.01.001 (Pubitemid 40558811)
29. RE Kontermann 2009 Strategies to extend plasma half-lives of recombinant antibodies Biodrugs 23 93 109 1:CAS:528:DC%2BD1MXovFSnsbs%3D 10.2165/00063030-200923020-00003
30. JC Almagro J Fransson 2008 Humanization of antibodies Frontiers in Bioscience 13 1619 1633 1:CAS:528:DC%2BD1cXhs1CgsLk%3D
31. RE Kontermann P Martineau CE Cummings A Karpas D Allen E Derbyshire G Winter 1997 Enzyme immunoassays using bispecific diabodies Immunotechnology 3 137 144 1:CAS:528:DyaK2sXlt1Sms7s%3D 10.1016/S1380-2933(97)00010-9 (Pubitemid 27356792)
32. R Stork KA Zettlitz D Müller M Rothdiener F-G Hanisch RE Kontermann 2008 N-glycosylation as novel strategy to improve pharmacokinetic properties of bispecific single-chain diabodies Journal of Biological Chemistry 283 7012 7804 10.1074/jbc.M709179200
33. D Müller A Karle B Meissburger I Höfig R Stork RE Kontermann 2007 Improved pharmacokinetics of recombinant bispecific antibody molecules by fusion to human serum albumin Journal of Biological Chemistry 282 12650 12660 10.1074/jbc.M700820200 (Pubitemid 47100581)
34. KR Abhinandan AC Martin 2007 Analyzing the "degree of humanness" of antibody sequences Journal of Molecular Biology 369 852 862 1:CAS:528:DC%2BD2sXlt1Sgs7Y%3D 10.1016/j.jmb.2007.02.100 (Pubitemid 46709913)
35. Martin, A. C. (2001). Protein sequence and structural analysis of antibody variable domains. In R. E. Kontermann & S. Dübel (Eds.), Antibody engineering (pp. 422-439). Heidelberg: Springer.
36. AC Martin JM Thornton 1996 Structural families of loops in homologous proteins: Automatic classification, modelling and application to antibodies Journal of Molecular Biology 263 800 815 1:CAS:528:DyaK28XntF2nsr4%3D 10.1006/jmbi.1996.0617 (Pubitemid 26395069)
37. F Friedrich S Stangl H Hahne B Küster P Köhler G Multhoff A Skerra 2010 Bacterial production and functional characterization of the Fab fragment of the murine IgG1/λ monoclonal antibody cmHsp70.1, a reagent for tumour diagnostics Protein Engineering, Design and Selection 23 161 168 1:CAS:528:DC%2BC3cXjslejtLk%3D 10.1093/protein/gzp095
38. H Bothmann A Plückthun 2000 The periplasmic Escherichia coli peptidylprolyl cis, trans-isomerase FkpA. I. Increased functional expression of antibody fragments with and without cis-prolines Journal of Biological Chemistry 275 17100 17105 1:CAS:528:DC%2BD3cXjvFCmtrY%3D 10.1074/jbc.M910233199 (Pubitemid 30398954)
39. DS Ow DY Lim PM Nissom A Camattari VV Wong 2010 Co-expression of Skp and KkpA chaperones improves cell viability and alters the global expression of stress response genes during scFvD1.3 production Microb Cell Fact 9 22 10.1186/1475-2859-9-22
40. MM Damschroder L Widjaja PS Gill V Krasnoperov W Jiang WF Dall'Acqua H Wu 2007 Framework shuffling of antibodies to reduce immunogenicity and manipulate functional and biophysical properties Molecular Immunology 44 3049 3060 1:CAS:528:DC%2BD2sXjtVWrtLo%3D 10.1016/j.molimm.2006.12.019 (Pubitemid 46412478)
41. Honegger, A. (2008). Engineering antibodies for stability and efficient folding. In Y. Chernajovsky & A. Nissim (Eds.), Therapeutic antibodies. Handbook of experimental pharmacology (pp. 47-68). Heidelberg: Springer.
42. A Wright SK Morrison 1993 Antibody variable region glycosylation: Biochemical and clinical effects Springer Seminars in Immunopathology 15 259 273 1:CAS:528:DyaK2cXltFymtw%3D%3D 10.1007/BF00201106
43. M Jacquemin CM Radcliffe R Lavend'Homme MR Wormald L Vanderelst G Wallays J Dewaele D Collen J Vermylen RA Dwek JM Saint-Remy PM Rudd M Dewerhin 2006 Variable region heavy chain glycosylation determines the anticoagulant activity of a factor VIII antibody Journal of Thrombosis and Haemostasis 4 1047 1055 1:CAS:528:DC%2BD28XltFajtbw%3D 10.1111/j.1538-7836.2006.01900.x
44. MS Co NM Avdalovic PC Caron MV Avdalovic DA Scheinberg C Queen 1992 Chimeric and humanized antibodies with specificity for the CD33 antigen Journal of Immunology 148 1149 1154 1:CAS:528:DyaK38XitVyrsb8%3D
45. MS Co DA Scheinberg NM Avdalovic K McGraw M Vasquez PC Caron C Queen 1993 Genetically engineered deglycosylation of the variable domain increases the affinity of an anti-CD33 monoclonal antibody Molecular Immunology 30 1361 1371 1:CAS:528:DyaK2cXmsVKn 10.1016/0161-5890(93)90097-U
46. P Carter L Presta CM Gorman JB Ridgway D Henner WL Wong AM Rowland C Kotts ME Carver HM Shepard 1992 Humanization of an anti-p185Her2 antibody for human cancer therapy Proceedings of the National Academy of Sciences of the United States of America 89 4285 4289 1:CAS:528:DyaK3sXitFSqtb0%3D 10.1073/pnas.89.10.4285
47. Stangl, S., Gehrmann, M., Dressel, R., Alves, F., Dullin, C., Themelis, G., Ntziachristos, V., Staeblein, E., Walch, A., Winkelmann, I., & Multhoff, G. (2010). In vivo imaging of CT26 mouse tumors by using cmHsp70.1 monoclonal antibody. Journal of Cellular and Molecular Medicine (epub ahead of print).
48. HR Hoogenboom 2005 Selecting and screening recombinant antibody libraries Nature Biotechnology 23 1105 1116 1:CAS:528:DC%2BD2MXpvVyrsb0%3D 10.1038/nbt1126 (Pubitemid 41486392)
49. LG Presta 2006 Engineering of therapeutic antibodies to minimize immunogenicity and optimize function Advanced Drug Delivery Reviews 58 640 656 1:CAS:528:DC%2BD28XoslKrsLY%3D 10.1016/j.addr.2006.01.026 (Pubitemid 44262411)
50. LG Presta 2008 Molecular engineering and design of therapeutic antibodies Current Opinion in Immunology 20 460 470 1:CAS:528:DC%2BD1cXpslSltL8%3D 10.1016/j.coi.2008.06.012
51. A Natsume R Niwa M Satoh 2009 Improving effector functions of antibodies for cancer treatment: Enhancing ADCC and CDC Drug Design, Development and Therapy 3 7 16 1:CAS:528:DC%2BD1MXoslSmsLc%3D